|
|
|
Insider
Information: |
Tobias Jeffrey K |
Relationship: |
EVP, R&D & CMO |
City: |
San Carlos |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
43,483 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$4,205,147 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
43,483 |
|
|
Total
Value |
$4,205,147 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurogesx Inc |
NGSX |
EVP Research & Dev & CMO |
2011-05-18 |
4,999 |
2009-11-25 |
0 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
EVP, R&D & CMO |
2015-03-05 |
38,484 |
2012-08-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2014-09-12 |
4 |
AS |
$171.22 |
$171,220 |
D/D |
(1,000) |
41,538 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2014-11-14 |
4 |
AS |
$173.32 |
$173,320 |
D/D |
(1,000) |
39,538 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2014-03-05 |
4 |
D |
$157.60 |
$185,022 |
D/D |
(1,174) |
48,103 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2013-11-11 |
4 |
AS |
$98.50 |
$233,741 |
D/D |
(2,373) |
44,405 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2013-09-09 |
4 |
OE |
$46.83 |
$234,150 |
D/D |
5,000 |
49,405 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2013-10-14 |
4 |
OE |
$46.83 |
$234,150 |
D/D |
5,000 |
49,405 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, R&D & CMO |
|
2015-02-10 |
4 |
OE |
$46.83 |
$234,150 |
D/D |
5,000 |
40,063 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2014-08-11 |
4 |
OE |
$46.83 |
$260,188 |
D/D |
4,933 |
47,471 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2013-08-09 |
4 |
D |
$80.88 |
$265,933 |
D/D |
(3,288) |
44,405 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, R&D & CMO |
|
2015-03-05 |
4 |
D |
$174.76 |
$284,859 |
D/D |
(1,630) |
38,484 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2013-08-12 |
4 |
OE |
$46.83 |
$351,225 |
D/D |
7,500 |
51,905 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2014-04-14 |
4 |
AS |
$128.54 |
$385,620 |
D/D |
(3,000) |
48,103 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2014-02-10 |
4 |
AS |
$152.83 |
$391,245 |
D/D |
(2,560) |
44,777 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2013-10-14 |
4 |
AS |
$82.53 |
$413,118 |
D/D |
(5,000) |
44,405 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2013-09-09 |
4 |
AS |
$87.11 |
$435,550 |
D/D |
(5,000) |
44,405 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2014-06-09 |
4 |
AS |
$146.24 |
$438,720 |
D/D |
(3,000) |
47,103 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2014-03-10 |
4 |
AS |
$152.99 |
$458,970 |
D/D |
(3,000) |
48,103 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2014-02-27 |
4 |
S |
$165.46 |
$496,380 |
D/D |
(3,000) |
41,777 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2013-08-12 |
4 |
AS |
$80.77 |
$605,775 |
D/D |
(7,500) |
44,405 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2014-08-11 |
4 |
D |
$133.86 |
$611,071 |
D/D |
(4,565) |
42,538 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2014-08-11 |
4 |
AS |
$135.42 |
$668,027 |
D/D |
(4,933) |
42,538 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Research & Dev and CMO |
|
2014-11-24 |
4 |
S |
$170.12 |
$782,231 |
D/D |
(4,598) |
34,940 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, R&D & CMO |
|
2015-02-10 |
4 |
AS |
$166.48 |
$834,118 |
D/D |
(5,000) |
35,063 |
0 |
- |
|
48 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|